BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Resverlogix Closes Previously Announced $87M Private Placement With Shenzhen Hepalink

  Each full warrant is exercisable at a price of $1.64 per share for a period of four years from the closing of the offering.

  December 4, 2017

   · 

  3 min read
• Business

  GW Pharmaceuticals Reports Fiscal Fourth Quarter 2017 and Year-End Financial Results and Operational Progress

  Cash and cash equivalents at 30 September 2017 of £241.2 million ($322.2 million) compared to £374.4 million as at 30 September 2016..

  December 4, 2017

   · 

  14 min read
• Biotech Beach

  Axonics Granted Seven New U.S. Patents Related to Its Implantable Sacral Neuromodulation Technology

  Axonics announced today that the United States Patent and Trademark Office has granted Axonics seven new U.S. patents along with numerous foreign counterparts relating to its implantable sacral neuromodulation technology.

  December 4, 2017

   · 

  2 min read
• CommScope and SwIFT Consortium Research Reveals Optimistic Future for Network Operators

  New fibre optic switching technologies could potentially automate manual processes and reduce energy costs across telecommunications, according to the study.

  December 4, 2017

   · 

  4 min read
• Biotech Beach

  Innovus Pharma Files Application for the Commercialization of ProstaGorx for Benign Prostatic Hyperplasia (“BPH”) as a Natural Health Product in Canada

  Innovus Pharma announced the filing of a Natural Health Product license application (“NHP”) in Canada for its ProstaGorx product.

  December 4, 2017

   · 

  5 min read
• Drug Development

  La Jolla Pharmaceutical Company Announces Initiation of Pivotal Clinical Study of LJPC‑401 in Patients With Beta Thalassemia

  LJ401-BT01 is a pivotal, multinational, multicenter, randomized, controlled study that is designed to enroll approximately 100 patients across 9 countries.

  December 4, 2017

   · 

  6 min read
• Business

  Mustang Bio Announces License Agreement With Harvard University, and Research Collaboration with Beth Israel Deaconess Medical Center, to Develop CRISPR/Cas9-Enhanced CAR T Therapies

  Under the deal, technologies related to the development of off-the-shelf CAR T, as well as CRISPR/Cas9 gene editing platforms, will be utilized in conjunction with Mustang’s CAR T cell therapies.

  December 4, 2017

   · 

  4 min read
• Drug Development

  XBiotech Announces Publication of Phase II Data From Hidradenitis Suppurativa Phase II Study in The Journal of Investigative Dermatology

  The publication highlights the efficacy of MABp1, in which the study’s primary endpoint was met in 60% of MABp1 treated patients compared to 10% of placebo patients.

  December 4, 2017

   · 

  5 min read
• Business

  VANC Pharmaceuticals Executes Share Purchase Agreement to Acquire HealthTab

  HealthTab is a lab-accurate, point-of-care testing platform designed to support the expanding role of pharmacists while offering new potential sources of revenue and growth for pharmacy owners.

  December 4, 2017

   · 

  6 min read
• Business

  Summit Therapeutics: Notice of Third Quarter Results

  The company will announce its financial results for the third quarter and nine months ended 31 October 2017 on 6 December 2017.

  December 4, 2017

   · 

  1 min read